0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical Topical Hemostatic Agent Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-22A11433
Home | Market Reports | Health| Medical Devices & Equipment
Global Medical Topical Hemostatic Agent Market Research Report 2022
BUY CHAPTERS

Global Medical Topical Hemostatic Agent Market Research Report 2025

Code: QYRE-Auto-22A11433
Report
January 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Medical Topical Hemostatic Agent Market Size

The global market for Medical Topical Hemostatic Agent was valued at US$ 8948 million in the year 2024 and is projected to reach a revised size of US$ 14370 million by 2031, growing at a CAGR of 7.1% during the forecast period.

Medical Topical Hemostatic Agent Market

Medical Topical Hemostatic Agent Market

Medical topical hemostatic agent are used in the setting of surgery or trauma as adjuncts to maintain hemostasis. Topical hemostat products include gelatin sponges, collagens, fibrin sealants, and active thrombin preparations. These agents are applied locally to stop blood flow.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medical Topical Hemostatic Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Topical Hemostatic Agent.
The Medical Topical Hemostatic Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medical Topical Hemostatic Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Topical Hemostatic Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Medical Topical Hemostatic Agent Market Report

Report Metric Details
Report Name Medical Topical Hemostatic Agent Market
Accounted market size in year US$ 8948 million
Forecasted market size in 2031 US$ 14370 million
CAGR 7.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Surgical Centers
  • Nursing Homes
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Medical Topical Hemostatic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Medical Topical Hemostatic Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Medical Topical Hemostatic Agent Market growing?

Ans: The Medical Topical Hemostatic Agent Market witnessing a CAGR of 7.1% during the forecast period 2025-2031.

What is the Medical Topical Hemostatic Agent Market size in 2031?

Ans: The Medical Topical Hemostatic Agent Market size in 2031 will be US$ 14370 million.

Who are the main players in the Medical Topical Hemostatic Agent Market report?

Ans: The main players in the Medical Topical Hemostatic Agent Market are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies

What are the Application segmentation covered in the Medical Topical Hemostatic Agent Market report?

Ans: The Applications covered in the Medical Topical Hemostatic Agent Market report are Hospitals, Surgical Centers, Nursing Homes

What are the Type segmentation covered in the Medical Topical Hemostatic Agent Market report?

Ans: The Types covered in the Medical Topical Hemostatic Agent Market report are Gelation Sponge, Oxidized Regenerated Cellulose Based Hemostats, Others

Recommended Reports

Hemostatic Products

Absorbable Agents

Sealants & Powders

1 Medical Topical Hemostatic Agent Market Overview
1.1 Product Definition
1.2 Medical Topical Hemostatic Agent by Type
1.2.1 Global Medical Topical Hemostatic Agent Market Value Comparison by Type (2024 VS 2031)
1.2.2 Gelation Sponge
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Others
1.3 Medical Topical Hemostatic Agent by Application
1.3.1 Global Medical Topical Hemostatic Agent Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Nursing Homes
1.4 Global Medical Topical Hemostatic Agent Market Size Estimates and Forecasts
1.4.1 Global Medical Topical Hemostatic Agent Revenue 2020-2031
1.4.2 Global Medical Topical Hemostatic Agent Sales 2020-2031
1.4.3 Global Medical Topical Hemostatic Agent Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Medical Topical Hemostatic Agent Market Competition by Manufacturers
2.1 Global Medical Topical Hemostatic Agent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Medical Topical Hemostatic Agent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Medical Topical Hemostatic Agent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Medical Topical Hemostatic Agent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medical Topical Hemostatic Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Topical Hemostatic Agent, Product Type & Application
2.7 Global Key Manufacturers of Medical Topical Hemostatic Agent, Date of Enter into This Industry
2.8 Global Medical Topical Hemostatic Agent Market Competitive Situation and Trends
2.8.1 Global Medical Topical Hemostatic Agent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Medical Topical Hemostatic Agent Players Market Share by Revenue
2.8.3 Global Medical Topical Hemostatic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medical Topical Hemostatic Agent Market Scenario by Region
3.1 Global Medical Topical Hemostatic Agent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Medical Topical Hemostatic Agent Sales by Region: 2020-2031
3.2.1 Global Medical Topical Hemostatic Agent Sales by Region: 2020-2025
3.2.2 Global Medical Topical Hemostatic Agent Sales by Region: 2026-2031
3.3 Global Medical Topical Hemostatic Agent Revenue by Region: 2020-2031
3.3.1 Global Medical Topical Hemostatic Agent Revenue by Region: 2020-2025
3.3.2 Global Medical Topical Hemostatic Agent Revenue by Region: 2026-2031
3.4 North America Medical Topical Hemostatic Agent Market Facts & Figures by Country
3.4.1 North America Medical Topical Hemostatic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Medical Topical Hemostatic Agent Sales by Country (2020-2031)
3.4.3 North America Medical Topical Hemostatic Agent Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Topical Hemostatic Agent Market Facts & Figures by Country
3.5.1 Europe Medical Topical Hemostatic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Medical Topical Hemostatic Agent Sales by Country (2020-2031)
3.5.3 Europe Medical Topical Hemostatic Agent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Topical Hemostatic Agent Market Facts & Figures by Region
3.6.1 Asia Pacific Medical Topical Hemostatic Agent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Medical Topical Hemostatic Agent Sales by Region (2020-2031)
3.6.3 Asia Pacific Medical Topical Hemostatic Agent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Medical Topical Hemostatic Agent Market Facts & Figures by Country
3.7.1 Latin America Medical Topical Hemostatic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Medical Topical Hemostatic Agent Sales by Country (2020-2031)
3.7.3 Latin America Medical Topical Hemostatic Agent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Topical Hemostatic Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Topical Hemostatic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Medical Topical Hemostatic Agent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Medical Topical Hemostatic Agent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Topical Hemostatic Agent Sales by Type (2020-2031)
4.1.1 Global Medical Topical Hemostatic Agent Sales by Type (2020-2025)
4.1.2 Global Medical Topical Hemostatic Agent Sales by Type (2026-2031)
4.1.3 Global Medical Topical Hemostatic Agent Sales Market Share by Type (2020-2031)
4.2 Global Medical Topical Hemostatic Agent Revenue by Type (2020-2031)
4.2.1 Global Medical Topical Hemostatic Agent Revenue by Type (2020-2025)
4.2.2 Global Medical Topical Hemostatic Agent Revenue by Type (2026-2031)
4.2.3 Global Medical Topical Hemostatic Agent Revenue Market Share by Type (2020-2031)
4.3 Global Medical Topical Hemostatic Agent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Medical Topical Hemostatic Agent Sales by Application (2020-2031)
5.1.1 Global Medical Topical Hemostatic Agent Sales by Application (2020-2025)
5.1.2 Global Medical Topical Hemostatic Agent Sales by Application (2026-2031)
5.1.3 Global Medical Topical Hemostatic Agent Sales Market Share by Application (2020-2031)
5.2 Global Medical Topical Hemostatic Agent Revenue by Application (2020-2031)
5.2.1 Global Medical Topical Hemostatic Agent Revenue by Application (2020-2025)
5.2.2 Global Medical Topical Hemostatic Agent Revenue by Application (2026-2031)
5.2.3 Global Medical Topical Hemostatic Agent Revenue Market Share by Application (2020-2031)
5.3 Global Medical Topical Hemostatic Agent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Ethicon
6.1.1 Ethicon Company Information
6.1.2 Ethicon Description and Business Overview
6.1.3 Ethicon Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Ethicon Medical Topical Hemostatic Agent Product Portfolio
6.1.5 Ethicon Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Medical Topical Hemostatic Agent Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Baxter International
6.3.1 Baxter International Company Information
6.3.2 Baxter International Description and Business Overview
6.3.3 Baxter International Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Baxter International Medical Topical Hemostatic Agent Product Portfolio
6.3.5 Baxter International Recent Developments/Updates
6.4 C. R. Bard
6.4.1 C. R. Bard Company Information
6.4.2 C. R. Bard Description and Business Overview
6.4.3 C. R. Bard Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 C. R. Bard Medical Topical Hemostatic Agent Product Portfolio
6.4.5 C. R. Bard Recent Developments/Updates
6.5 The Medicines Company
6.5.1 The Medicines Company Company Information
6.5.2 The Medicines Company Description and Business Overview
6.5.3 The Medicines Company Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 The Medicines Company Medical Topical Hemostatic Agent Product Portfolio
6.5.5 The Medicines Company Recent Developments/Updates
6.6 Anika Therapeutics
6.6.1 Anika Therapeutics Company Information
6.6.2 Anika Therapeutics Description and Business Overview
6.6.3 Anika Therapeutics Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Anika Therapeutics Medical Topical Hemostatic Agent Product Portfolio
6.6.5 Anika Therapeutics Recent Developments/Updates
6.7 Advanced Medical Solutions
6.7.1 Advanced Medical Solutions Company Information
6.7.2 Advanced Medical Solutions Description and Business Overview
6.7.3 Advanced Medical Solutions Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Advanced Medical Solutions Medical Topical Hemostatic Agent Product Portfolio
6.7.5 Advanced Medical Solutions Recent Developments/Updates
6.8 Integra LifeSciences
6.8.1 Integra LifeSciences Company Information
6.8.2 Integra LifeSciences Description and Business Overview
6.8.3 Integra LifeSciences Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Integra LifeSciences Medical Topical Hemostatic Agent Product Portfolio
6.8.5 Integra LifeSciences Recent Developments/Updates
6.9 B Braun Melsungen
6.9.1 B Braun Melsungen Company Information
6.9.2 B Braun Melsungen Description and Business Overview
6.9.3 B Braun Melsungen Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.9.4 B Braun Melsungen Medical Topical Hemostatic Agent Product Portfolio
6.9.5 B Braun Melsungen Recent Developments/Updates
6.10 Gelita Medical
6.10.1 Gelita Medical Company Information
6.10.2 Gelita Medical Description and Business Overview
6.10.3 Gelita Medical Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Gelita Medical Medical Topical Hemostatic Agent Product Portfolio
6.10.5 Gelita Medical Recent Developments/Updates
6.11 Equimedical
6.11.1 Equimedical Company Information
6.11.2 Equimedical Description and Business Overview
6.11.3 Equimedical Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Equimedical Medical Topical Hemostatic Agent Product Portfolio
6.11.5 Equimedical Recent Developments/Updates
6.12 Vascular Solutions
6.12.1 Vascular Solutions Company Information
6.12.2 Vascular Solutions Description and Business Overview
6.12.3 Vascular Solutions Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Vascular Solutions Medical Topical Hemostatic Agent Product Portfolio
6.12.5 Vascular Solutions Recent Developments/Updates
6.13 Marine Polymer Technologies
6.13.1 Marine Polymer Technologies Company Information
6.13.2 Marine Polymer Technologies Description and Business Overview
6.13.3 Marine Polymer Technologies Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Marine Polymer Technologies Medical Topical Hemostatic Agent Product Portfolio
6.13.5 Marine Polymer Technologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Topical Hemostatic Agent Industry Chain Analysis
7.2 Medical Topical Hemostatic Agent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Topical Hemostatic Agent Production Mode & Process Analysis
7.4 Medical Topical Hemostatic Agent Sales and Marketing
7.4.1 Medical Topical Hemostatic Agent Sales Channels
7.4.2 Medical Topical Hemostatic Agent Distributors
7.5 Medical Topical Hemostatic Agent Customer Analysis
8 Medical Topical Hemostatic Agent Market Dynamics
8.1 Medical Topical Hemostatic Agent Industry Trends
8.2 Medical Topical Hemostatic Agent Market Drivers
8.3 Medical Topical Hemostatic Agent Market Challenges
8.4 Medical Topical Hemostatic Agent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Medical Topical Hemostatic Agent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Medical Topical Hemostatic Agent Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Medical Topical Hemostatic Agent Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Medical Topical Hemostatic Agent Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Medical Topical Hemostatic Agent Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Medical Topical Hemostatic Agent Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Medical Topical Hemostatic Agent Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Medical Topical Hemostatic Agent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Medical Topical Hemostatic Agent, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Medical Topical Hemostatic Agent, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Medical Topical Hemostatic Agent, Product Type & Application
 Table 12. Global Key Manufacturers of Medical Topical Hemostatic Agent, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Medical Topical Hemostatic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Topical Hemostatic Agent as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Medical Topical Hemostatic Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Medical Topical Hemostatic Agent Sales by Region (2020-2025) & (K Units)
 Table 18. Global Medical Topical Hemostatic Agent Sales Market Share by Region (2020-2025)
 Table 19. Global Medical Topical Hemostatic Agent Sales by Region (2026-2031) & (K Units)
 Table 20. Global Medical Topical Hemostatic Agent Sales Market Share by Region (2026-2031)
 Table 21. Global Medical Topical Hemostatic Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Medical Topical Hemostatic Agent Revenue Market Share by Region (2020-2025)
 Table 23. Global Medical Topical Hemostatic Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Medical Topical Hemostatic Agent Revenue Market Share by Region (2026-2031)
 Table 25. North America Medical Topical Hemostatic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Medical Topical Hemostatic Agent Sales by Country (2020-2025) & (K Units)
 Table 27. North America Medical Topical Hemostatic Agent Sales by Country (2026-2031) & (K Units)
 Table 28. North America Medical Topical Hemostatic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Medical Topical Hemostatic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Medical Topical Hemostatic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Medical Topical Hemostatic Agent Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Medical Topical Hemostatic Agent Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Medical Topical Hemostatic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Medical Topical Hemostatic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Medical Topical Hemostatic Agent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Medical Topical Hemostatic Agent Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Medical Topical Hemostatic Agent Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Medical Topical Hemostatic Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Medical Topical Hemostatic Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Medical Topical Hemostatic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Medical Topical Hemostatic Agent Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Medical Topical Hemostatic Agent Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Medical Topical Hemostatic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Medical Topical Hemostatic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Medical Topical Hemostatic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Medical Topical Hemostatic Agent Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Medical Topical Hemostatic Agent Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Medical Topical Hemostatic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Medical Topical Hemostatic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Medical Topical Hemostatic Agent Sales (K Units) by Type (2020-2025)
 Table 51. Global Medical Topical Hemostatic Agent Sales (K Units) by Type (2026-2031)
 Table 52. Global Medical Topical Hemostatic Agent Sales Market Share by Type (2020-2025)
 Table 53. Global Medical Topical Hemostatic Agent Sales Market Share by Type (2026-2031)
 Table 54. Global Medical Topical Hemostatic Agent Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Medical Topical Hemostatic Agent Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Medical Topical Hemostatic Agent Revenue Market Share by Type (2020-2025)
 Table 57. Global Medical Topical Hemostatic Agent Revenue Market Share by Type (2026-2031)
 Table 58. Global Medical Topical Hemostatic Agent Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Medical Topical Hemostatic Agent Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Medical Topical Hemostatic Agent Sales (K Units) by Application (2020-2025)
 Table 61. Global Medical Topical Hemostatic Agent Sales (K Units) by Application (2026-2031)
 Table 62. Global Medical Topical Hemostatic Agent Sales Market Share by Application (2020-2025)
 Table 63. Global Medical Topical Hemostatic Agent Sales Market Share by Application (2026-2031)
 Table 64. Global Medical Topical Hemostatic Agent Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Medical Topical Hemostatic Agent Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Medical Topical Hemostatic Agent Revenue Market Share by Application (2020-2025)
 Table 67. Global Medical Topical Hemostatic Agent Revenue Market Share by Application (2026-2031)
 Table 68. Global Medical Topical Hemostatic Agent Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Medical Topical Hemostatic Agent Price (US$/Unit) by Application (2026-2031)
 Table 70. Ethicon Company Information
 Table 71. Ethicon Description and Business Overview
 Table 72. Ethicon Medical Topical Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Ethicon Medical Topical Hemostatic Agent Product
 Table 74. Ethicon Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Medical Topical Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Medical Topical Hemostatic Agent Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Baxter International Company Information
 Table 81. Baxter International Description and Business Overview
 Table 82. Baxter International Medical Topical Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Baxter International Medical Topical Hemostatic Agent Product
 Table 84. Baxter International Recent Developments/Updates
 Table 85. C. R. Bard Company Information
 Table 86. C. R. Bard Description and Business Overview
 Table 87. C. R. Bard Medical Topical Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. C. R. Bard Medical Topical Hemostatic Agent Product
 Table 89. C. R. Bard Recent Developments/Updates
 Table 90. The Medicines Company Company Information
 Table 91. The Medicines Company Description and Business Overview
 Table 92. The Medicines Company Medical Topical Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. The Medicines Company Medical Topical Hemostatic Agent Product
 Table 94. The Medicines Company Recent Developments/Updates
 Table 95. Anika Therapeutics Company Information
 Table 96. Anika Therapeutics Description and Business Overview
 Table 97. Anika Therapeutics Medical Topical Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Anika Therapeutics Medical Topical Hemostatic Agent Product
 Table 99. Anika Therapeutics Recent Developments/Updates
 Table 100. Advanced Medical Solutions Company Information
 Table 101. Advanced Medical Solutions Description and Business Overview
 Table 102. Advanced Medical Solutions Medical Topical Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Advanced Medical Solutions Medical Topical Hemostatic Agent Product
 Table 104. Advanced Medical Solutions Recent Developments/Updates
 Table 105. Integra LifeSciences Company Information
 Table 106. Integra LifeSciences Description and Business Overview
 Table 107. Integra LifeSciences Medical Topical Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Integra LifeSciences Medical Topical Hemostatic Agent Product
 Table 109. Integra LifeSciences Recent Developments/Updates
 Table 110. B Braun Melsungen Company Information
 Table 111. B Braun Melsungen Description and Business Overview
 Table 112. B Braun Melsungen Medical Topical Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. B Braun Melsungen Medical Topical Hemostatic Agent Product
 Table 114. B Braun Melsungen Recent Developments/Updates
 Table 115. Gelita Medical Company Information
 Table 116. Gelita Medical Description and Business Overview
 Table 117. Gelita Medical Medical Topical Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Gelita Medical Medical Topical Hemostatic Agent Product
 Table 119. Gelita Medical Recent Developments/Updates
 Table 120. Equimedical Company Information
 Table 121. Equimedical Description and Business Overview
 Table 122. Equimedical Medical Topical Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Equimedical Medical Topical Hemostatic Agent Product
 Table 124. Equimedical Recent Developments/Updates
 Table 125. Vascular Solutions Company Information
 Table 126. Vascular Solutions Description and Business Overview
 Table 127. Vascular Solutions Medical Topical Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Vascular Solutions Medical Topical Hemostatic Agent Product
 Table 129. Vascular Solutions Recent Developments/Updates
 Table 130. Marine Polymer Technologies Company Information
 Table 131. Marine Polymer Technologies Description and Business Overview
 Table 132. Marine Polymer Technologies Medical Topical Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Marine Polymer Technologies Medical Topical Hemostatic Agent Product
 Table 134. Marine Polymer Technologies Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Medical Topical Hemostatic Agent Distributors List
 Table 138. Medical Topical Hemostatic Agent Customers List
 Table 139. Medical Topical Hemostatic Agent Market Trends
 Table 140. Medical Topical Hemostatic Agent Market Drivers
 Table 141. Medical Topical Hemostatic Agent Market Challenges
 Table 142. Medical Topical Hemostatic Agent Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Medical Topical Hemostatic Agent
 Figure 2. Global Medical Topical Hemostatic Agent Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Medical Topical Hemostatic Agent Market Share by Type: 2024 & 2031
 Figure 4. Gelation Sponge Product Picture
 Figure 5. Oxidized Regenerated Cellulose Based Hemostats Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Medical Topical Hemostatic Agent Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Medical Topical Hemostatic Agent Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Surgical Centers
 Figure 11. Nursing Homes
 Figure 12. Global Medical Topical Hemostatic Agent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Medical Topical Hemostatic Agent Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Medical Topical Hemostatic Agent Sales (2020-2031) & (K Units)
 Figure 15. Global Medical Topical Hemostatic Agent Average Price (US$/Unit) & (2020-2031)
 Figure 16. Medical Topical Hemostatic Agent Report Years Considered
 Figure 17. Medical Topical Hemostatic Agent Sales Share by Manufacturers in 2024
 Figure 18. Global Medical Topical Hemostatic Agent Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Medical Topical Hemostatic Agent Players: Market Share by Revenue in Medical Topical Hemostatic Agent in 2024
 Figure 20. Medical Topical Hemostatic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Medical Topical Hemostatic Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Medical Topical Hemostatic Agent Sales Market Share by Country (2020-2031)
 Figure 23. North America Medical Topical Hemostatic Agent Revenue Market Share by Country (2020-2031)
 Figure 24. United States Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Medical Topical Hemostatic Agent Sales Market Share by Country (2020-2031)
 Figure 27. Europe Medical Topical Hemostatic Agent Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Medical Topical Hemostatic Agent Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Medical Topical Hemostatic Agent Revenue Market Share by Region (2020-2031)
 Figure 35. China Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Medical Topical Hemostatic Agent Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Medical Topical Hemostatic Agent Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Medical Topical Hemostatic Agent Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Medical Topical Hemostatic Agent Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Medical Topical Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Medical Topical Hemostatic Agent by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Medical Topical Hemostatic Agent by Type (2020-2031)
 Figure 56. Global Medical Topical Hemostatic Agent Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Medical Topical Hemostatic Agent by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Medical Topical Hemostatic Agent by Application (2020-2031)
 Figure 59. Global Medical Topical Hemostatic Agent Price (US$/Unit) by Application (2020-2031)
 Figure 60. Medical Topical Hemostatic Agent Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart